Lead Plaintiff Attorney Calls Ruling in Vioxx Case 'A Positive Development' for His Client and Others Suing Merck
31 Août 2006 - 10:49PM
PR Newswire (US)
NEWPORT BEACH, Calif., Aug. 31 /PRNewswire/ -- In response to
Merck's statement Wednesday that the company would seek a new trial
on "all liability issues," Mark P. Robinson, Jr., lead plaintiff
lawyer in the $51 million jury verdict against Merck, said a
federal judge's ruling on compensatory damages, in fact, supports
the jury's finding of liability and is a "positive development" for
his client and others suing Merck. "This is a significantly
positive decision for all of those whose lives have been damaged or
destroyed by Vioxx," said Robinson, of the Newport Beach, CA., law
firm Robinson, Calcagnie & Robinson. "The judge ruled that the
jury's findings -- that Merck negligently failed to warn and
committed deceit-by-concealment with Vioxx -- were reasonable
findings. Though the court ruled that the compensatory damages were
excessive, the judge also said he was not troubled by the punitive
damages award. Further, he is going to allow one jury to try both
the compensatory and the punitive damages award again in a single
trial. All of this taken together is a very positive development
for those who are victims of Vioxx." Robinson is lead counsel for
former FBI special agent Gerald Barnett. A jury in New Orleans on
Aug. 17 awarded the 62-year-old Barnett $50 million in compensatory
damages and $1 million in punitive damages. Barnett suffered a
heart attack in 2002 after taking Vioxx continuously for
approximately 55 months for pain from osteoarthritis. Judge Eldon
Fallon on Wednesday ruled the $50 million in compensatory damages
was too high based on Barnett's health following the heart attack.
But he supported the punitive award. More specifically, the judge
in making his ruling on damages reinforced the merits of the
verdict against Merck. Judge Fallon wrote: "The Court takes this
opportunity to note that the jury's findings on liability are
reasonable in this case. All three of Plaintiff's claims revolve
around the safety risks of Vioxx, what Merck knew about any such
risks, when Merck knew this information, and what Merck should have
done about it. Considering all of the evidence in the light most
favorable to the Plaintiff, the Court concludes that the jury's
findings for the Plaintiff on his negligent failure-to-warn and
deceit-by-concealment claims were reasonable." DATASOURCE:
Robinson, Calcagnie & Robinson CONTACT: Mark P. Robinson, Jr.
of Robinson, Calcagnie & Robinson, +1-949-720-1288; or Robert
G. Magnuson, +1-949-278-7515, for Robinson, Calcagnie &
Robinson
Copyright